 |
인쇄하기
취소
|
Korean companies set to launch high-dose Gleevec pills
Several Korean drug makers are poised to release high-dose Gleevec tablets, according to Dasan Medichem, a local formulation company.
Dasan has worked together with the country's seven leading pharmaceutical companies to develop Gleevec (imatinib) 400 mg. To this end, the company completed Phase 2 clinical trials for this drug on February 2012.
“Imatinib 400 mg tablets are expected to im...
Dasan has worked together with the country's seven leading pharmaceutical companies to develop Gleevec (imatinib) 400 mg. To this end, the company completed Phase 2 clinical trials for this drug on February 2012.
“Imatinib 400 mg tablets are expected to im...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.